Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 4:41 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 533212 | NSE: GKB

GKB Ophthalmics Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹161.67Undervalued by 195.02%vs CMP ₹54.80

P/E (15.0) × ROE (12.7%) × BV (₹104.00) × DY (2.00%)

Defaults: P/E=15

₹111.71Undervalued by 103.85%vs CMP ₹54.80
MoS: +50.9% (Strong)Confidence: 44/100 (Low)Models: 3 Under, 1 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹105.2841%Under (+92.1%)
Net Asset ValueAssets₹105.2324%Under (+92%)
ROCE CapitalReturns₹19.6916%Over (-64.1%)
Revenue MultipleRevenue₹216.4218%Under (+294.9%)
Consensus (4 models)₹111.71100%Undervalued
Key Drivers: EPS CAGR -34.9% drags value — could be higher if earnings stabilize. | Wide model spread (₹20–₹216) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -34.9% · Defaults: P/E=15

*Investments are subject to market risks

Investment Snapshot

55
GKB Ophthalmics Ltd scores 55/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health54/100 · Moderate
ROCE 6.0% WeakROE 12.7% GoodD/E 0.18 Low debtInterest Coverage 0.0x RiskyProfitable 1/5 years Inconsistent
Smart Money50/100 · Moderate
FII holding stable No changePromoter holding at 51.1% Stable
Earnings Quality40/100 · Moderate
OPM contracting (6% → -1%) Declining
Quarterly Momentum80/100 · Strong
Revenue (4Q): +51% YoY AcceleratingOPM: 2.4% (up 6.0% YoY) Margin expansion
Industry Rank50/100 · Moderate
ROCE 6.0% vs industry 6.0% Average3Y sales CAGR: 15% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

GKB Ophthalmics Ltd Investor Signals

Computed from valuation, cash flow, balance sheet, ownership and quarterly trend data already available in this stock page.

Value Trap Score
40/100
Moderate
Derived from: Cheapness + weak quality + weak cash support
Current data: P/E 0.0 | ROCE 6.0% | ROE 12.7% | CFO/NP N/A
Balance Sheet Stress
0/100
Comfortable
Derived from: Leverage + debt servicing + liquidity + debt trend
Current data: D/E 0.18x | IntCov 0.0x | Current 1.94x | Borrow/Reserve 0.31x
Cash Flow Reliability
100/100
Strong
Derived from: Cash backing of earnings + working capital pressure
Current data: CFO ₹0 Cr | NP ₹-7 Cr | CFO/NP N/A
Ownership Accumulation
+25
Neutral
Derived from: FII + DII + promoter direction, adjusted by crowding
Current data: FII 0.00 pp | DII N/A | Prom +0.07 pp
Business Momentum
-17
Early weakness
Derived from: Latest quarter sales + profit + OPM change
Current data: Q Sales +88.2% | Q NP -62.0% | Q OPM -7.6 pp
Derived FieldValueHow it is derived
Valuation Gap %+103.9%((Fair Value - CMP) / CMP) × 100
Borrowings / Reserves0.31xLatest borrowings divided by latest reserves
CFO / Net ProfitN/ALatest operating cash flow divided by latest net profit
FII Change0.00 ppLatest FII% minus previous FII%
DII ChangeN/ALatest DII% minus previous DII%
Promoter Change+0.07 ppLatest promoter% minus previous promoter%
Shareholder Count Change+60Latest shareholder count minus previous count
Quarterly Sales Change+88.2%Latest quarter sales vs previous quarter sales
Quarterly Profit Change-62.0%Latest quarter net profit vs previous quarter net profit
Quarterly OPM Change-7.6 ppLatest quarter OPM minus previous quarter OPM

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:41 am

Market Cap 27.6 Cr.
Current Price 54.8
Intrinsic Value₹111.71
High / Low 91.7/45.2
Stock P/E
Book Value 104
Dividend Yield0.00 %
ROCE6.00 %
ROE12.7 %
Face Value 10.0
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for GKB Ophthalmics Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
GKB Ophthalmics Ltd 27.6 Cr. 54.8 91.7/45.2 1040.00 %6.00 %12.7 % 10.0
Industry Average0 Cr54.800104.000.00%6.00%12.70%10.00

All Competitor Stocks of GKB Ophthalmics Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 19.1119.9622.2620.4024.0421.5626.0226.1425.8031.0232.3130.1756.79
Expenses 19.1820.3520.9120.6924.6621.5624.9826.2026.7433.8831.5127.1555.43
Operating Profit -0.07-0.391.35-0.29-0.620.001.04-0.06-0.94-2.860.803.021.36
OPM % -0.37%-1.95%6.06%-1.42%-2.58%0.00%4.00%-0.23%-3.64%-9.22%2.48%10.01%2.39%
Other Income -0.030.230.350.310.350.600.280.280.480.350.210.370.87
Interest 0.400.430.430.460.440.570.550.550.630.630.770.660.73
Depreciation 0.401.630.720.730.730.720.760.770.770.800.800.820.82
Profit before tax -0.90-2.220.55-1.17-1.44-0.690.01-1.10-1.86-3.94-0.561.910.68
Tax % 18.89%-4.95%0.00%0.00%0.00%30.43%600.00%5.45%2.69%4.82%14.29%3.66%-4.41%
Net Profit -1.11-2.080.54-1.19-1.44-0.890.11-1.15-1.91-4.13-0.641.840.70
EPS in Rs -2.04-3.811.03-2.32-2.48-1.81-0.50-2.42-4.03-7.04-2.023.170.87

Last Updated: March 3, 2026, 9:34 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 5:50 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 4135447678575957717588109150
Expenses 3434447577565655667288112148
Operating Profit 81-121122541-32
OPM % 18%2%-2%2%2%2%4%4%7%5%1%-3%2%
Other Income 11124021211222
Interest 3221111212223
Depreciation 1211244333333
Profit before tax 5-283-1-2-2-120-3-7-2
Tax % 46%-37%50%12%-15%-30%0%-19%0%14%8%5%
Net Profit 4043-1-1-2-120-3-7-2
EPS in Rs 9.610.009.516.24-2.34-2.37-3.65-1.812.52-0.34-5.57-13.97-5.02
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152016-20172017-20182018-20192019-20202020-20212021-20222022-20232024-2025
YoY Net Profit Growth (%)-100.00%-25.00%-133.33%0.00%-100.00%50.00%300.00%-100.00%-133.33%
Change in YoY Net Profit Growth (%)0.00%75.00%-108.33%133.33%-100.00%150.00%250.00%-400.00%-33.33%

GKB Ophthalmics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:12%
5 Years:13%
3 Years:15%
TTM:25%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:-118%
Stock Price CAGR
10 Years:3%
5 Years:5%
3 Years:-7%
1 Year:-37%
Return on Equity
10 Years:-3%
5 Years:-3%
3 Years:-6%
Last Year:-13%

Last Updated: September 5, 2025, 3:36 pm

Balance Sheet

Last Updated: December 4, 2025, 2:57 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 4444455555555
Reserves 36364143415054585858554748
Borrowings 13977101415121211111415
Other Liabilities 21261728282528323538435974
Total Liabilities 737569828394102107110112114125141
Fixed Assets 14121318182626242319181717
CWIP 1111000134444
Investments 1516103011222222
Other Assets 4446466064687580828791102119
Total Assets 737569828394102107110112114125141

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 67-11-3-34375-34-3
Cash from Investing Activity + -2-01541-10-4-17-41-23
Cash from Financing Activity + -5-6-3-111343-2-2-21
Net Cash Flow -010-1074-7-0-41-0
Free Cash Flow 67-13-9-5-6-010-22-6
CFO/OP 99%1,117%639%-112%-190%346%154%300%105%-71%865%118%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-5.00-8.00-8.00-5.00-9.00-13.00-13.00-10.00-7.00-7.00-10.00-17.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 18519114311812915015512510013411785
Inventory Days 345424285225223289301349307298245250
Days Payable 163343156169168217234234208183202195
Cash Conversion Cycle 367271272174184222223239199249160141
Working Capital Days 101971561111151101101171051359778
ROCE %14%-0%-1%3%0%-2%-1%3%4%2%-1%-6%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 59.09%59.18%50.86%50.88%50.93%50.95%50.95%50.98%50.99%51.06%51.06%51.13%
FIIs 1.79%1.79%1.79%1.79%1.79%1.79%1.79%1.79%1.79%1.79%1.79%1.79%
Public 39.13%39.02%47.36%47.34%47.28%47.26%47.28%47.23%47.23%47.16%47.17%47.09%
No. of Shareholders 1,9332,0302,1152,2332,3702,6902,5102,5392,5382,5502,6012,661

Shareholding Pattern Chart

No. of Shareholders

GKB Ophthalmics Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) -13.98-5.58-0.332.53-1.80
Diluted EPS (Rs.) -13.98-5.58-0.332.53-1.80
Cash EPS (Rs.) -8.28-0.045.788.973.52
Book Value[Excl.RevalReserv]/Share (Rs.) 103.24127.37133.51133.75131.54
Book Value[Incl.RevalReserv]/Share (Rs.) 103.24127.37133.51133.75131.54
Revenue From Operations / Share (Rs.) 216.22175.09149.73140.73112.84
PBDIT / Share (Rs.) -2.884.139.1411.918.62
PBIT / Share (Rs.) -9.00-1.613.536.612.38
PBT / Share (Rs.) -13.71-5.390.213.68-3.08
Net Profit / Share (Rs.) -14.41-5.800.163.67-2.72
NP After MI And SOA / Share (Rs.) -13.98-5.58-0.332.53-1.80
PBDIT Margin (%) -1.332.366.108.467.64
PBIT Margin (%) -4.16-0.922.354.692.11
PBT Margin (%) -6.33-3.070.142.61-2.72
Net Profit Margin (%) -6.66-3.310.112.61-2.41
NP After MI And SOA Margin (%) -6.46-3.18-0.221.79-1.59
Return on Networth / Equity (%) -13.53-4.70-0.262.01-1.44
Return on Capital Employeed (%) -7.22-1.192.504.721.75
Return On Assets (%) -5.62-2.45-0.141.15-0.84
Long Term Debt / Equity (X) 0.050.010.010.020.01
Total Debt / Equity (X) 0.270.190.170.180.18
Asset Turnover Ratio (%) 0.900.770.340.330.26
Current Ratio (X) 1.591.892.021.911.94
Quick Ratio (X) 0.781.031.090.951.01
Inventory Turnover Ratio (X) 2.410.380.620.640.58
Interest Coverage Ratio (X) -0.611.102.754.062.14
Interest Coverage Ratio (Post Tax) (X) -2.06-0.531.052.250.68
Enterprise Value (Cr.) 35.4942.0556.0846.0539.02
EV / Net Operating Revenue (X) 0.320.470.740.640.68
EV / EBITDA (X) -24.4520.1712.177.678.98
MarketCap / Net Operating Revenue (X) 0.270.490.720.650.72
Price / BV (X) 0.580.730.870.730.65
Price / Net Operating Revenue (X) 0.270.490.720.650.72
EarningsYield -0.23-0.060.000.02-0.02

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

GKB Ophthalmics Ltd. is a Public Limited Listed company incorporated on 10/12/1981 and has its registered office in the State of Goa, India. Company's Corporate Identification Number(CIN) is L26109GA1981PLC000469 and registration number is 000469. Currently Company is involved in the business activities of Manufacture of ophthalmic goods, eyeglasses, sunglasses, lenses ground to prescription, contact lenses, safety goggles etc.. Company's Total Operating Revenue is Rs. 32.75 Cr. and Equity Capital is Rs. 5.04 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Lenses/Optical Care16-A, Tivim Industrial Estate, Mapusa Goa 403526Contact not found
Management
NamePosition Held
Mr. K G GuptaChairman & Managing Director
Mr. Vikram GuptaDirector
Mr. Ninad G KamatDirector
Mr. Purushottam S MantriDirector
Mrs. Sandhya Ajit KamatDirector
Mr. Cedric LoboDirector

FAQ

What is the intrinsic value of GKB Ophthalmics Ltd and is it undervalued?

As of 05 April 2026, GKB Ophthalmics Ltd's intrinsic value is ₹111.71, which is 103.85% higher than the current market price of ₹54.80, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (12.7 %), book value (₹104), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of GKB Ophthalmics Ltd?

GKB Ophthalmics Ltd is trading at ₹54.80 as of 05 April 2026, with a FY2026-2027 high of ₹91.7 and low of ₹45.2. The stock is currently near its 52-week low. Market cap stands at ₹27.6 Cr..

Is GKB Ophthalmics Ltd financially healthy?

Key indicators for GKB Ophthalmics Ltd: ROCE of 6.00 % is on the lower side compared to the industry average of 6.00%. Dividend yield is 0.00 %.

Is GKB Ophthalmics Ltd profitable and how is the profit trend?

GKB Ophthalmics Ltd reported a net profit of ₹-7 Cr in Mar 2025 on revenue of ₹109 Cr. Compared to ₹2 Cr in Mar 2022, the net profit shows a declining trend.

Does GKB Ophthalmics Ltd pay dividends?

GKB Ophthalmics Ltd has a dividend yield of 0.00 % at the current price of ₹54.80. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in GKB Ophthalmics Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports